Skip to main content
. Author manuscript; available in PMC: 2010 May 17.
Published in final edited form as: J Infect Dis. 2006 Nov 20;195(1):118–123. doi: 10.1086/509896

Figure 1.

Figure 1

Percentage of subjects with detectable immune responses to mycobacterial antigens by in vivo and in vitro tests. IFN, interferon; LAM, antibody to Mycobacterium tuberculosis lipoarabinomannin; LPA, lymphocyte proliferation assay; MAS, Mycobacterium avium sensitin; PPD, M. tuberculosis purified protein derivative.